Clinical Trials Directory

Trials / Completed

CompletedNCT04582175

Comparison Between Two Revascularization Strategies in MVD Patients With Uncomplicated ST-elevation MI

A Retrospective, One Center Comparison of Outcomes Between Complete Revascularization by PCI at the Time of PPCI or During the Index Hospital Admission in One Hundred MVD Patients With ST-elevation MI Uncomplicated by Cardiogenic Shock

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
University of Oradea · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers

Summary

The study aimed to compare major adverse cardiac and cerebrovascular events(MACCE) and mortality at one year between two strategies: complete revascularization including non-culprit lesions percutaneous coronary intervention(PCI) during primary PCI(PPCI) versus complete revascularisation during the same hospital admission in multi-vascular coronary artery disease(MVD) patients presenting with ST-elevation myocardial infarction(STEMI) uncomplicated by cardiogenic shock.

Detailed description

Complete revascularisation in MVD patients with STEMI uncomplicated by cardiogenic shock has been shown to improve outcomes, however the optimal timing of treatment of the non-culprit lesions is not known. The 2018 ESC/EACTS Guidelines on myocardial revascularization states that "routine revascularization of non-IRA (infarct related artery) lesions should be considered in patients with multivessel disease before hospital discharge". Our trial showed that among the fore mentioned patients there was no difference regarding outcomes when using a strategy of complete revascularization with non-culprit lesions PCI during PPCI or during the same hospital admission.

Conditions

Interventions

TypeNameDescription
PROCEDUREangioplastyangioplasty of all non-culprit lesions

Timeline

Start date
2020-07-01
Primary completion
2020-09-01
Completion
2020-09-05
First posted
2020-10-09
Last updated
2020-10-09

Locations

1 site across 1 country: Romania

Source: ClinicalTrials.gov record NCT04582175. Inclusion in this directory is not an endorsement.